International Conference on Parkinson’s disease and Movement disorder 2015
Track 1: Epidemiology of Parkinsons and Movement Disorders
Improving economy and health in countries like USA, Germany, has increased the life span and changed the emphasis from communicable to non-communicable diseases. It is expected that the prevalence of parkinson’s disease in the 7MM (US, France, Italy, Spain, Germany, Brazil, and Japan) and UK will increase from 3.2m people in 2012 to 4.3m people in 2022. The global treatment for syndromes of the movement disorders market is anticipated to grow from an estimated $ 12,859.8 million in 2014 to $ 21,154.8 million in 2020 at a CAGR of 8.6% during the forecast period. This increase the prevalence of age-related diseases and movement disorders like Parkinson's disease (PD). We review epidemiological studies to describe: a) Developments in interdisciplinary of Parkinson and movement disorders, b) Aggregation and Protein Misfolding and c) potential of epidemiological research in countries with multiple ethnic races and environmental risks for PD, d) methodological issues, e) Prevalence of movement disorders
Ad posted 60 days ago SEE LATEST ANNOUNCEMENTS
Report this ad as:
Write review
Leave your comments on this ad
Offensive messages and spam will be removed
You're not sending an SMS, type the entire word without spelling errors

Related ads